229 related articles for article (PubMed ID: 25031220)
21. Differential roles for group 1 mGluR subtypes in induction and expression of chemically induced hippocampal long-term depression.
Volk LJ; Daly CA; Huber KM
J Neurophysiol; 2006 Apr; 95(4):2427-38. PubMed ID: 16421200
[TBL] [Abstract][Full Text] [Related]
22. N-{4-Chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide (CPPHA) acts through a novel site as a positive allosteric modulator of group 1 metabotropic glutamate receptors.
Chen Y; Goudet C; Pin JP; Conn PJ
Mol Pharmacol; 2008 Mar; 73(3):909-18. PubMed ID: 18056795
[TBL] [Abstract][Full Text] [Related]
23. Dose-dependent effect of CDPPB, the mGluR5 positive allosteric modulator, on recognition memory is associated with GluR1 and CREB phosphorylation in the prefrontal cortex and hippocampus.
Uslaner JM; Parmentier-Batteur S; Flick RB; Surles NO; Lam JS; McNaughton CH; Jacobson MA; Hutson PH
Neuropharmacology; 2009; 57(5-6):531-8. PubMed ID: 19627999
[TBL] [Abstract][Full Text] [Related]
24. Behavioral and functional evidence of metabotropic glutamate receptor 2/3 and metabotropic glutamate receptor 5 dysregulation in cocaine-escalated rats: factor in the transition to dependence.
Hao Y; Martin-Fardon R; Weiss F
Biol Psychiatry; 2010 Aug; 68(3):240-8. PubMed ID: 20416862
[TBL] [Abstract][Full Text] [Related]
25. The role of mGluR5 on the therapeutic effects of ketamine in Wistar rats.
Gokalp D; Unal G
Psychopharmacology (Berl); 2024 Jul; 241(7):1399-1415. PubMed ID: 38459971
[TBL] [Abstract][Full Text] [Related]
26. Dissociable effects of mGluR5 allosteric modulation on distinct forms of impulsivity in rats: interaction with NMDA receptor antagonism.
Isherwood SN; Pekcec A; Nicholson JR; Robbins TW; Dalley JW
Psychopharmacology (Berl); 2015 Sep; 232(18):3327-44. PubMed ID: 26063678
[TBL] [Abstract][Full Text] [Related]
27. Molecular mechanisms of group I metabotropic glutamate receptor mediated LTP and LTD in basolateral amygdala in vitro.
Chen A; Hu WW; Jiang XL; Potegal M; Li H
Psychopharmacology (Berl); 2017 Feb; 234(4):681-694. PubMed ID: 28028604
[TBL] [Abstract][Full Text] [Related]
28. Rescue of Impaired mGluR5-Driven Endocannabinoid Signaling Restores Prefrontal Cortical Output to Inhibit Pain in Arthritic Rats.
Kiritoshi T; Ji G; Neugebauer V
J Neurosci; 2016 Jan; 36(3):837-50. PubMed ID: 26791214
[TBL] [Abstract][Full Text] [Related]
29. mGluR5 Positive and Negative Allosteric Modulators Differentially Affect Dendritic Spine Density and Morphology in the Prefrontal Cortex.
LaCrosse AL; Taylor SB; Nemirovsky NE; Gass JT; Olive MF
CNS Neurol Disord Drug Targets; 2015; 14(4):476-85. PubMed ID: 25921744
[TBL] [Abstract][Full Text] [Related]
30. Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression.
Hughes ZA; Neal SJ; Smith DL; Sukoff Rizzo SJ; Pulicicchio CM; Lotarski S; Lu S; Dwyer JM; Brennan J; Olsen M; Bender CN; Kouranova E; Andree TH; Harrison JE; Whiteside GT; Springer D; O'Neil SV; Leonard SK; Schechter LE; Dunlop J; Rosenzweig-Lipson S; Ring RH
Neuropharmacology; 2013 Mar; 66():202-14. PubMed ID: 22551786
[TBL] [Abstract][Full Text] [Related]
31. A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5.
O'Brien JA; Lemaire W; Chen TB; Chang RS; Jacobson MA; Ha SN; Lindsley CW; Schaffhauser HJ; Sur C; Pettibone DJ; Conn PJ; Williams DL
Mol Pharmacol; 2003 Sep; 64(3):731-40. PubMed ID: 12920211
[TBL] [Abstract][Full Text] [Related]
32. Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons.
Pisani A; Gubellini P; Bonsi P; Conquet F; Picconi B; Centonze D; Bernardi G; Calabresi P
Neuroscience; 2001; 106(3):579-87. PubMed ID: 11591458
[TBL] [Abstract][Full Text] [Related]
33. Involvement of metabotropic glutamate receptor 5 in the inhibition of methamphetamine-associated contextual memory after prolonged extinction training.
Huang CH; Yu YJ; Chang CH; Gean PW
J Neurochem; 2016 Apr; 137(2):216-25. PubMed ID: 26748780
[TBL] [Abstract][Full Text] [Related]
34. Discovery of positive allosteric modulators of metabotropic glutamate receptor subtype 5 (mGluR5).
Williams DL; Lindsley CW
Curr Top Med Chem; 2005; 5(9):825-46. PubMed ID: 16178729
[TBL] [Abstract][Full Text] [Related]
35. Role of metabotropic glutamate receptor subtype mGluR1 in brief nociception and central sensitization of primate STT cells.
Neugebauer V; Chen PS; Willis WD
J Neurophysiol; 1999 Jul; 82(1):272-82. PubMed ID: 10400956
[TBL] [Abstract][Full Text] [Related]
36. A novel mGluR5 antagonist, MFZ 10-7, inhibits cocaine-taking and cocaine-seeking behavior in rats.
Keck TM; Zou MF; Bi GH; Zhang HY; Wang XF; Yang HJ; Srivastava R; Gardner EL; Xi ZX; Newman AH
Addict Biol; 2014 Mar; 19(2):195-209. PubMed ID: 24001208
[TBL] [Abstract][Full Text] [Related]
37. Cocaine Withdrawal Impairs mGluR5-Dependent Long-Term Depression in Nucleus Accumbens Shell Neurons of Both Direct and Indirect Pathways.
Huang CC; Liang YC; Lee CC; Hsu KS
Mol Neurobiol; 2015 Dec; 52(3):1223-1233. PubMed ID: 25319571
[TBL] [Abstract][Full Text] [Related]
38. Activation of lateral hypothalamic mGlu1 and mGlu5 receptors elicits feeding in rats.
Charles JR; Duva MA; Ramirez GJ; Lara RL; Yang CR; Stanley BG
Neuropharmacology; 2014 Apr; 79():59-65. PubMed ID: 24219858
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of social novelty discrimination by positive allosteric modulators at metabotropic glutamate 5 receptors: adolescent administration prevents adult-onset deficits induced by neonatal treatment with phencyclidine.
Clifton NE; Morisot N; Girardon S; Millan MJ; Loiseau F
Psychopharmacology (Berl); 2013 Feb; 225(3):579-94. PubMed ID: 22983144
[TBL] [Abstract][Full Text] [Related]
40. A novel class of positive allosteric modulators of metabotropic glutamate receptor subtype 1 interact with a site distinct from that of negative allosteric modulators.
Hemstapat K; de Paulis T; Chen Y; Brady AE; Grover VK; Alagille D; Tamagnan GD; Conn PJ
Mol Pharmacol; 2006 Aug; 70(2):616-26. PubMed ID: 16645124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
